Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Loaded in Injectable Platelet-Rich Fibrin in Treatment of Periodontitis
NCT07316582Phase 4Enrolling by invitation
- Sponsor
- Al-Azhar University
- Start
- Nov 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of melatonin in periodontitis (3 arms), sponsored by Al-Azhar University. Primary endpoint: Clinical attachment level at 6 months. Started Nov 2025; status: enrolling by invitation.
02
Drugs
melatonin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07316582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07316582.